Search research articles
Contact Us
Filters
Showing results (401-410 of 461) with videos related to
Page
of 47
Sort By:
Nature Medicine
|
June 8, 2019
Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma
Antoni Ribas, Donald Lawrence, Victoria Atkinson, et al.
Scientific Reports
|
October 7, 2017
Emergence and clonal spread of colistin resistance due to multiple mutational mechanisms in carbapenemase-producing Klebsiella pneumoniae in London
Jonathan A Otter, Michel Doumith, Frances Davies, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 19, 2020
Disease Prevention Not Decolonization: A Model for Fecal Microbiota Transplantation in Patients Colonized With Multidrug-resistant Organisms
Rohma Ghani, Benjamin H Mullish, Julie A K McDonald, et al.
Journal of Primary Care & Community Health
|
July 28, 2025
Risk Factors and Comorbidities Associated With Vitamin B<sub>12</sub> Deficiency in an Adult Population
Alexandra Lane, Lucinda Lau, Christy Alhannat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 10, 2017
Long-Term Outcomes in Patients With BRAF V600-Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib
Georgina V Long, Zeynep Eroglu, Jeffrey Infante, et al.
Journal of Hepatology
|
March 29, 2003
Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis
Herbert Tilg, Rajiv Jalan, Arthur Kaser, et al.
The Lancet. Oncology
|
June 11, 2016
Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial
David Planchard, Benjamin Besse, Harry J M Groen, et al.
Hepatology (Baltimore, Md.)
|
August 6, 2019
Ammonia Scavenging Prevents Progression of Fibrosis in Experimental Nonalcoholic Fatty Liver Disease
Francesco De Chiara, Karen Louise Thomsen, Abeba Habtesion, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 22, 2019
Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trials
Axel Hauschild, Paolo A Ascierto, Dirk Schadendorf, et al.
Journal of Hepatology
|
June 21, 2020
Determinants of mortality in patients with cirrhosis and uncontrolled variceal bleeding
Rahul Kumar, Annarein J C Kerbert, M Faisal Sheikh, et al.
Page
of 47
Search research articles
Search
Showing results (401-410 of 461) with videos related to
Sort By:
Page
of 47
Nature Medicine
|
June 8, 2019
Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma
Antoni Ribas, Donald Lawrence, Victoria Atkinson, et al.
Scientific Reports
|
October 7, 2017
Emergence and clonal spread of colistin resistance due to multiple mutational mechanisms in carbapenemase-producing Klebsiella pneumoniae in London
Jonathan A Otter, Michel Doumith, Frances Davies, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 19, 2020
Disease Prevention Not Decolonization: A Model for Fecal Microbiota Transplantation in Patients Colonized With Multidrug-resistant Organisms
Rohma Ghani, Benjamin H Mullish, Julie A K McDonald, et al.
Journal of Primary Care & Community Health
|
July 28, 2025
Risk Factors and Comorbidities Associated With Vitamin B<sub>12</sub> Deficiency in an Adult Population
Alexandra Lane, Lucinda Lau, Christy Alhannat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 10, 2017
Long-Term Outcomes in Patients With BRAF V600-Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib
Georgina V Long, Zeynep Eroglu, Jeffrey Infante, et al.
Journal of Hepatology
|
March 29, 2003
Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis
Herbert Tilg, Rajiv Jalan, Arthur Kaser, et al.
The Lancet. Oncology
|
June 11, 2016
Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial
David Planchard, Benjamin Besse, Harry J M Groen, et al.
Hepatology (Baltimore, Md.)
|
August 6, 2019
Ammonia Scavenging Prevents Progression of Fibrosis in Experimental Nonalcoholic Fatty Liver Disease
Francesco De Chiara, Karen Louise Thomsen, Abeba Habtesion, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 22, 2019
Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trials
Axel Hauschild, Paolo A Ascierto, Dirk Schadendorf, et al.
Journal of Hepatology
|
June 21, 2020
Determinants of mortality in patients with cirrhosis and uncontrolled variceal bleeding
Rahul Kumar, Annarein J C Kerbert, M Faisal Sheikh, et al.
Page
of 47